Boehringer

INGELVAC® PRRS KV
An inactivated, oil adjuvanted Porcine Reproductive and Respiratory Syndrome (PRRS) virus vaccine containing at least 2.5 log10 Immuno Fluorescence units PRRS virus P120 strain per 2 ml dose.n
Page 1 of 2
Back to Main PageIngelvac® PRRS: Making History
In the 1980s a previously unrecognised disease syndrome caused heavy production losses in pig herds in North America.
Normal non infected porcine alveolar macrophage (Electronic Microscope)
Normal non infected porcine alveolar macrophage (Electronic Microscope) In the following years this syndrome appeared in many other major pig producing areas of North America and Europe.

In Europe a devastating epidemic, with estimates of 1 million or more pigs lost, occurred in the winter of 1990/91. It has since spread worldwide, becoming endemic in the major swine producing areas of the world. The disease was formerly described by different names, such as Pig plague 1989, Mystery Swine Disease (MSD), Abortus Blauw, Blue Ear Pig Disease, or Porcine Epidemic and Abortion and Respiratory Syndrome (PEARS). In April 1991 a meeting of European Community veterinarians agreed on the name, Porcine Reproductive and Respiratory Syndrom (PRRS), which was subsequently adopted internationally.

The PRRSyndrome is caused by a virus which was identified in Europe (the Netherlands) in 1991 by Wensvoort et al.The group called it Lelystad virus after the town that contained their research institute. In the USA Boehringer Ingelheim Animal Health Inc. isolated the American strain of the virus, recognised as ATCC VR-2332, in a proprietary cell line from the lung of a gnotobiotic pig, infected with field virus provided by the University of Minnesota.
Normal non infected porcine alveolar macrophage (Electronic Microscope)
PRRS infected porcine alveolar macrophage
PRRS virus is an RNA virus which grows preferentially in porcine alveolar macrophages. Its molecular characteristics have led to its classification as a member of the Arterivirus group.

Control of PRRS in UK pig herds has until now consisted mainly of strict hygiene management and class segregation. These measures have provided only partial control and the recent introduction of a live vaccine against PRRS for baby pigs has done nothing to help the reproductive performance of infected herds. Ingelvac PRRS KV is the first vaccine licensed to enhance reproductive performance impaired by infection with the virus.

Boehringer Ingelheim is an internationally respected name in pig health. This product launch heralds the arrival of Boehringer Ingelheim Vetmedica as a fully committed partner to pig producers in the UK.
Back to Main PagePRRS: The Disease
Reproductive loss through PRRS
Acute PRRS in the breeding herd can cause death and resorption of the foetuses when the virus infects them at an early stage of gestation. It is then associated with an early return to oestrus of the sows and reduced farrowing rates.

The virus is especially pathogenic during the second half of gestation: late infection (around day 90) can cause haemorrhagic lesions of the umbilical cord and so lead to abortions, early farrowing (by 3-5 days), an increase in stillbirths, mummies and pre-weaning mortality. It therefore results in a decrease in total births, live births and weaned litter sizes. Furthermore, piglets born to infected animals often show increased susceptibility to secondary infections.

Respiratory
Suckling and fattening pigs suffer respiratory symptoms and death due to PRRS infection contracted from virus circulating in the herd. Respiratory symptoms are often aggravated by secondary infections, possibly due to impairment of macrophages in the lung.
 
‘The Blue Eared Pig Disease’
The names given to the disease often have some reference to blue ears. One of the early clinical signs included a blue discoloration of the ears.

Reproductive PRRS’
Reproductive PRRS is associated with abortions, weak and stillborn piglets, early farrowing and a reduction of other reproductive parameters.


‘Secondary Infections’
Piglets from infected sows are prone to secondary infections such as Streptococcus suis, APP, Enzootic Pneumonia, Haemophilus parasuis, etc.



‘Respiratory PRRS’
Respiratory PRRS is characterised by difficulty in breathing, eyelid oedema, sneezing, pyrexia, stunted growth and poor food conversion.

Back to Main PagePRRS: Diagnosis
Clinical Symptoms in the Breeding Herd


(Note: the number and the severity of these symptoms can vary greatly, depending on the PRRS status of the farm)

Not only is PRRS a problem in its own right but there is increasing evidence that it is an important co-factor in the development of Post Weaning Multi-Systemic Wasting Syndrome (PMWS). Co-infections with PRRS Virus and Porcine Circo Virus 2 (PCV2) are now thought to be the main causative agents of the syndrome. This has been observed by several different authors and in various countries. Experimental dual infection with both viruses has been shown to potentiate the replication of PCV2 which could explain the fact that PMWS seems to be clinically more severe in cases of co-infections with PCV2 and PRRSV compared to infections with PCV2 alone. PMWS is an increasingly important issue in UK pig herds, quickly spreading and causing significant economic loss.

How to diagnose PRRS?
Different diagnostic tools are available to differentiate PRRS infection from other diseases. A tentative diagnosis is made on the basis of clinical signs such as maternal reproductive failure and respiratory disease in growing pigs. Definitive diagnosis however, requires further diagnostic tests carried out on materials from infected animals.

Why is it important to test for PRRS?
Many infected herds show clinical signs that are easily confused with other swine diseases. Knowing the herd status is an important aid in determining the most appropriate course of action.

Next Page Back to Main Page

Our Newest
Web Site


TheBioenergySite

Sunday 7th September

Search Site
On-Line Book Shop